Cardinal Health, Inc. $CAH Holdings Lowered by Hsbc Holdings PLC

Hsbc Holdings PLC decreased its stake in Cardinal Health, Inc. (NYSE:CAH) by 11.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 612,473 shares of the company’s stock after selling 81,872 shares during the quarter. Hsbc Holdings PLC owned 0.26% of Cardinal Health worth $126,038,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Norges Bank purchased a new stake in Cardinal Health during the fourth quarter valued at about $790,344,000. Wellington Management Group LLP boosted its holdings in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after buying an additional 3,511,579 shares during the period. Holocene Advisors LP increased its position in shares of Cardinal Health by 141.4% in the third quarter. Holocene Advisors LP now owns 1,926,170 shares of the company’s stock worth $302,332,000 after acquiring an additional 1,128,358 shares in the last quarter. Marshall Wace LLP increased its position in shares of Cardinal Health by 1,328.1% in the fourth quarter. Marshall Wace LLP now owns 951,259 shares of the company’s stock worth $195,484,000 after acquiring an additional 884,648 shares in the last quarter. Finally, Barclays PLC raised its holdings in shares of Cardinal Health by 109.3% during the third quarter. Barclays PLC now owns 1,584,214 shares of the company’s stock valued at $248,658,000 after acquiring an additional 827,446 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on CAH. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 15th. Barclays boosted their target price on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Leerink Partners restated an “outperform” rating and issued a $275.00 target price on shares of Cardinal Health in a report on Monday, March 9th. Citigroup decreased their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Finally, TD Cowen lifted their price target on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a report on Friday, May 1st. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Price Performance

NYSE CAH opened at $222.08 on Monday. The firm has a market capitalization of $52.01 billion, a price-to-earnings ratio of 33.96, a price-to-earnings-growth ratio of 1.21 and a beta of 0.52. The company has a 50 day simple moving average of $204.34 and a 200-day simple moving average of $209.28. Cardinal Health, Inc. has a 52-week low of $137.75 and a 52-week high of $233.60.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.